Aclarion is engaged in the manufacturing of innovative diagnostic apparatuses. On 22 April, Aclarion is planning to go public on the NASDAQ. We are analysing the issuer's business and financial reports to determine whether its stock might be of interest to investors.
aclarion inc
1 post
are complex instruments and come with a high 
of losing 
rapidly due to 
. 65.68% of retail investor accounts lose 
when trading 
with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high